{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Filgotinib&page=2", "query": { "intervention": "Filgotinib", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Filgotinib&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-05T08:10:27.540Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04115748", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "Placebo to match adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 67, "start_date": "2019-12-03", "completion_date": "2021-05-11", "has_results": true, "last_update_posted_date": "2022-05-16", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 24, "location_summary": "Covina, California • Brandon, Florida • DeBary, Florida + 20 more", "locations": [ { "city": "Covina", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04115748" }, { "nct_id": "NCT04608344", "title": "Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Pravastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 27, "start_date": "2020-11-04", "completion_date": "2021-01-13", "has_results": true, "last_update_posted_date": "2022-06-14", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04608344" }, { "nct_id": "NCT02885181", "title": "Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "GS-9876", "type": "DRUG" }, { "name": "Filgotinib", "type": "DRUG" }, { "name": "GS-9876 placebo", "type": "DRUG" }, { "name": "Filgotinib placebo", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 83, "start_date": "2016-09-21", "completion_date": "2017-09-20", "has_results": true, "last_update_posted_date": "2018-09-19", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 9, "location_summary": "DeBary, Florida • Sarasota, Florida • Canton, Georgia + 6 more", "locations": [ { "city": "DeBary", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Canton", "state": "Georgia" }, { "city": "Elizabethtown", "state": "Kentucky" }, { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02885181" }, { "nct_id": "NCT05479058", "title": "A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2022-07-26", "completion_date": "2023-10-09", "has_results": true, "last_update_posted_date": "2024-10-04", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 5, "location_summary": "Miami, Florida • Naples, Florida • Columbia, Maryland + 2 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Naples", "state": "Florida" }, { "city": "Columbia", "state": "Maryland" }, { "city": "Rapid City", "state": "South Dakota" }, { "city": "Chesapeake", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05479058" }, { "nct_id": "NCT03025308", "title": "Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alfasigma S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2731, "start_date": "2017-02-28", "completion_date": "2025-05-16", "has_results": true, "last_update_posted_date": "2026-07-27", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 72, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Phoenix, Arizona + 65 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03025308" }, { "nct_id": "NCT02886728", "title": "Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "MTX", "type": "DRUG" }, { "name": "Placebo to match MTX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1252, "start_date": "2016-08-08", "completion_date": "2019-05-08", "has_results": true, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 45, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Tucson, Arizona + 42 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02886728" }, { "nct_id": "NCT02914561", "title": "Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1372, "start_date": "2016-10-31", "completion_date": "2022-11-11", "has_results": true, "last_update_posted_date": "2023-12-18", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 101, "location_summary": "Dothan, Alabama • Sun City, Arizona • Coronado, California + 82 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02914561" }, { "nct_id": "NCT03207815", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Noninfectious Uveitis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 74, "start_date": "2017-07-26", "completion_date": "2021-04-22", "has_results": true, "last_update_posted_date": "2022-01-21", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 15, "location_summary": "Palo Alto, California • Golden, Colorado • Chicago, Illinois + 12 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Golden", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Oak Park", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207815" }, { "nct_id": "NCT03134222", "title": "Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cutaneous Lupus Erythematosus" ], "interventions": [ { "name": "Lanraplenib", "type": "DRUG" }, { "name": "Filgotinib", "type": "DRUG" }, { "name": "Lanraplenib placebo", "type": "DRUG" }, { "name": "Filgotinib placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 47, "start_date": "2017-05-24", "completion_date": "2019-12-18", "has_results": true, "last_update_posted_date": "2020-06-09", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 13, "location_summary": "Beverly Hills, California • Fullerton, California • Los Angeles, California + 10 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03134222" }, { "nct_id": "NCT01888874", "title": "Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "GLPG0634", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lakefront Biotherapeutics NV", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 599, "start_date": "2013-07-17", "completion_date": "2015-05-14", "has_results": true, "last_update_posted_date": "2020-11-17", "last_synced_at": "2026-09-05T08:10:27.540Z", "location_count": 28, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Phoenix, Arizona + 25 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hemet", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01888874" } ] }